PLUS THERAPEUTICS, INC. — Director's Dealing 2011

Feb 3, 2011

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2010-11-18

Reporting Person: Townsend John (Controller)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	250	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option	$2.52	2015-01-20	Common Stock (1667)		Direct
Employee Stock Option	$6.01	2015-10-24	Common Stock (3600)		Direct
Employee Stock Option	$5.45	2017-04-02	Common Stock (7438)		Direct
Employee Stock Option	$3.6	2019-01-02	Common Stock (6500)		Direct
Employee Stock Option	$2.02	2019-05-07	Common Stock (5000)		Direct
Employee Stock Option	$6.71	2020-02-05	Common Stock (20000)		Direct

Footnotes

F1: The Employee Stock Options vest 1/48th each month from date of grant.